Ennature Bio Pharma lists on NSE and BSE, targets branded nutraceuticals growth
The portfolio includes thiocolchicoside, colchicine, nicotine, and vinpocetine, serving over 150 customers across 26 countries, with exports at 54% of segment revenue
We haven't written up this one. Hindu BusinessLine has the full story — the link below goes straight to it.